Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin

Pediatric Research

Volumn 69, Issue 1, 2011, Pages 34-39

  Deboer, Mark D ^a   Li, Yongli ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; FOLLITROPIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; DELAYED PUBERTY; DIET RESTRICTION; FEMALE; FOLLITROPIN BLOOD LEVEL; FOOD INTAKE; HISTOLOGY; MALE; MOUSE; NONHUMAN; PENIS GLANS; PREPUBERTY; PREPUCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; COLITIS; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLICLE STIMULATING HORMONE; HUMANS; LEPTIN; MALE; MICE; MICE, INBRED C57BL; PUBERTY, DELAYED; RADIOIMMUNOASSAY; TESTIS; TESTOSTERONE;

EID: 78650807538     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181ffee6c     Document Type: Article

References (35)

1. Ballinger AB, Savage MO, Sanderson IR 2003 Delayed puberty associated with inflammatory bowel disease. Pediatr Res 53:205-210
2. Brain CE, Savage MO 1994 Growth and puberty in chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 8:83-100
3. Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, Passariello R, Cucchiara S 2007 Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13:416-423
4. DeBoer MD, Barnes BH 2009 The importance of treatment regimens and pubertal status for growth in IBD. J Pediatr 154:936-937
5. Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC 2006 Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 12:885-913 (Pubitemid 44352716)
6. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250-252
7. Smith JT, Acohido BV, Clifton DK, Steiner RA 2006 KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J Neuroendocrinol 18:298-303
8. Farooqi IS 2002 Leptin and the onset of puberty: insights from rodent and human genetics. Semin Reprod Med 20:139-144
9. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S 1999 Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879-884
10. Kaminski BA, Palmert MR 2008 Genetic control of pubertal timing. Curr Opin Pediatr 20:458-464
11. Azooz OG, Farthing MJ, Savage MO, Ballinger AB 2001 Delayed puberty and response to testosterone in a rat model of colitis. Am J Physiol Regul Integr Comp Physiol 281:R1483-R1491
12. DeBoer MD, Li Y, Cohn S 2010 Colitis causes delay in puberty in female mice out of proportion to changes in leptin and corticosterone. J Gastroenterol 45:277-284
13. Adair LS, Gordon-Larsen P 2001 Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health 91:642-644
14. Kaplowitz PB 2008 Link between body fat and the timing of puberty. Pediatrics 121:S208-S217
15. Lee JM, Kaciroti N, Appugliese D, Corwyn RF, Bradley RH, Lumeng JC 2010 Body mass index and timing of pubertal initiation in boys. Arch Pediatr Adolesc Med 164:139-144
16. Wirtz S, Neufert C, Weigmann B, Neurath MF 2007 Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:541-546
17. Kolho KL, Huhtaniemi I 1989 Neonatal treatment of male rats with a gonadotropin-releasing hormone antagonist results in altered function of the pituitary-testicular axis in adult age. Biol Reprod 41:1084-1090
18. Korenbrot CC, Huhtaniemi IT, Weiner RI 1977 Preputial separation as an external sign of pubertal development in the male rat. Biol Reprod 17:298-303
19. Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, Pizarro TT, Cominelli F 2003 TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci USA 100:8366-8371
20. Bland JM, Altman DG 2004 The logrank test. BMJ 328:1073
21. Simon D 2002 Puberty in chronically diseased patients. Horm Res 57:53-56
22. Wong SC, Macrae VE, McGrogan P, Ahmed SF 2006 The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation. J Pediatr Gastroenterol Nutr 43:144-155
23. Feagins LA, Kane SV 2009 Sexual and reproductive issues for men with inflammatory bowel disease. Am J Gastroenterol 104:768-773
24. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusugami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shimoyama T, Kishimoto T 2004 A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126:989-996
25. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H 2000 IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164:4878-4882
26. Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR 2005 Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 102:13260-13265
27. Uno JK, Kolek OI, Hines ER, Xu H, Timmermann BN, Kiela PR, Ghishan FK 2006 The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis. Gastroenterology 131:497-509
28. Froicu M, Cantorna MT 2007 Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 8:5
29. Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, Calixto JB 2008 The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 84:1213-1221
30. Walters TD, Gilman AR, Griffiths AM 2007 Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis 13:424-430
31. Kalra PS, Fuentes M, Sahu A, Kalra SP 1990 Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH. Endocrinology 127:2381-2386
32. Rivier C, Vale W 1990 Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology 127:849-856
33. Nappi RE, Rivest S 1997 Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: an evaluation at the transcriptional level. Endocrinology 138:1374-1384
34. Huang BM, Leu SF, Yang HY, Norman RL 2001 Testosterone effects on luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the mouse. J Androl 22:507-513
35. Sairam MR, Krishnamurthy H 2001 The role of follicle-stimulating hormone in spermatogenesis: lessons from knockout animal models. Arch Med Res 32:601-608